| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6122719 | Journal of Infection | 2015 | 9 Pages |
Abstract
Our results suggest flucloxacillin in combination with a single protein-synthesis inhibitor such as clindamycin would give the best treatment outcome.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Claire E. Turner, Shiranee Sriskandan,